Showing results (171-180 of 247) with videos related to
Sort By:
Pageof 25
Journal of Chromatography. A|November 23, 2005
Automatic program for peak detection and deconvolution of multi-overlapped chromatographic signals part II: peak model and deconvolution algorithmsG Vivó-Truyols, J R Torres-Lapasió, A M van Nederkassel, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|November 1, 1995
Food odor thresholds in relation to age, nutritional, and health statusM I Griep, T F Mets, A Vercruysse, et al.Journal of Chromatography|January 29, 1993
Determination of leucovorin and 5-fluorouracil in plasma by high-performance liquid chromatographyC Vandenbosch, S van Belle, M de Smet, et al.Journal of Pharmaceutical and Biomedical Analysis|July 1, 1997
Optimisation of the reversed phase liquid chromatographic separation of atovaquone, proguanil and related substancesP F de Aguiar, Y V Vander Heyden, Y Van Oost, et al.Journal of Chromatography. A|August 7, 2004
Selection of reversed-phase liquid chromatographic columns with diverse selectivity towards the potential separation of impurities in drugsE Van Gyseghem, M Jimidar, R Sneyers, et al.Analytical Chemistry|May 31, 2011
Elimination of uninformative variables for multivariate calibrationV Centner, D L Massart, O E de Noord, et al.Journal of Chromatography|May 8, 1992
High-performance liquid chromatographic determination of navelbine in MO4 mouse fibrosarcoma cells and biological fluidsS J Van Belle, M De Smet, C Monsaert, et al.International Journal of Pharmaceutics|February 13, 2001
Evaluation of dissolution profiles using principal component analysisE Adams, R De Maesschalck, B De Spiegeleer, et al.Cell Death & Disease|March 4, 2011
Glucocorticoids induce long-lasting effects in neural stem cells resulting in senescence-related alterationsR Bose, M Moors, R Tofighi, et al.Clinical Pharmacology and Therapeutics|October 22, 2010
Conditional approval and approval under exceptional circumstances as regulatory instruments for stimulating responsible drug innovation in EuropeW P C Boon, E H M Moors, A Meijer, et al.Pageof 25